Email me when Loomis Sayles & Co L P files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 705 | $83.8B | +$2.18B | -$3.23B | -$1.06B | NVDA, TSLA, META, ORCL, NFLX | 13F-HR | 11/13/2025, 09:38 AM |
| Q2 2025 | 715 | $79.2B | +$2.08B | -$2.59B | -$510M | NVDA, META, NFLX, AMZN, TSLA | 13F-HR | 8/13/2025, 09:54 AM |
| Q1 2025 | 725 | $68.6B | +$1.12B | -$4.11B | -$2.99B | NVDA, META, AMZN, NFLX, TSLA | 13F-HR | 5/14/2025, 04:12 PM |
| Q4 2024 | 716 | $78.4B | +$2.41B | -$4.95B | -$2.54B | NVDA, TSLA, META, AMZN, NFLX | 13F-HR | 2/12/2025, 09:25 AM |
| Q3 2024 | 690 | $75.3B | +$2.63B | -$2.71B | -$79.4M | NVDA, META, TSLA, AMZN, GOOGL | 13F-HR | 11/13/2024, 09:43 AM |
| Q2 2024 | 705 | $71.6B | +$7.43B | -$2B | +$5.44B | NVDA, META, AMZN, GOOGL, TSLA | 13F-HR | 8/13/2024, 11:17 AM |
| Q1 2024 | 692 | $69.4B | +$2.31B | -$5.27B | -$2.96B | NVDA, META, AMZN, V, GOOGL | 13F-HR | 5/14/2024, 11:23 AM |
| Q4 2023 | 968 | $64.1B | +$1.33B | -$2.3B | -$977M | META, NVDA, AMZN, BA, V | 13F-HR | 2/13/2024, 11:12 AM |
| Q3 2023 | 904 | $57.4B | +$2.25B | -$3.52B | -$1.27B | META, NVDA, AMZN, TSLA, GOOGL | 13F-HR | 11/9/2023, 02:59 PM |
| Q2 2023 | 967 | $61.1B | +$1.89B | -$4B | -$2.12B | NVDA, META, AMZN, TSLA, V | 13F-HR | 8/11/2023, 01:17 PM |
| Q1 2023 | 967 | $56.6B | +$2.8B | -$2.94B | -$143M | NVDA, META, V, BA, AMZN | Restatement | 5/15/2023, 04:42 PM |
| Q4 2022 | 848 | $49.2B | +$1.67B | -$4.69B | -$3.02B | V, BA, NVDA, AMZN, MSFT | 13F-HR | 2/10/2023, 04:15 PM |
| Q3 2022 | 945 | $48.6B | +$4.28B | -$2.98B | +$1.31B | AMZN, V, MSFT, GOOGL, NVDA | 13F-HR | 11/14/2022, 09:47 AM |
| Q2 2022 | 967 | $53.1B | +$4.5B | -$6.49B | -$1.99B | AMZN, V, MSFT, GOOGL, NVDA | 13F-HR | 8/5/2022, 09:54 AM |
| Q1 2022 | 1,000 | $73.6B | +$7.05B | -$7.64B | -$586M | AMZN, NVDA, V, MSFT, GOOGL | 13F-HR | 5/13/2022, 10:36 AM |
| Q4 2021 | 762 | $81.1B | +$3.18B | -$6.74B | -$3.56B | NVDA, AMZN, META, MSFT, V | 13F-HR | 2/14/2022, 11:26 AM |
| Q3 2021 | 882 | $79.7B | +$6.08B | -$2.76B | +$3.33B | AMZN, NVDA, META, V, CRM | 13F-HR | 11/12/2021, 10:13 AM |
| Q2 2021 | 822 | $80.9B | +$2.69B | -$5.18B | -$2.49B | AMZN, META, NVDA, V, BABA | 13F-HR | 8/13/2021, 09:52 AM |
| Q1 2021 | 830 | $76.4B | +$3.21B | -$4.49B | -$1.28B | AMZN, META, V, DE, BA | 13F-HR | 5/17/2021, 05:02 PM |
| Q4 2020 | 791 | $74.8B | +$4.46B | -$4.67B | -$215M | AMZN, META, V, ADSK, BABA | 13F-HR | 2/12/2021, 11:42 AM |
| Q3 2020 | 644 | $67.9B | +$1.91B | -$1.83B | +$81.5M | AMZN, BABA, META, V, NVDA | 13F-HR | 11/12/2020, 11:56 AM |
| Q2 2020 | 683 | $61.4B | +$6.22B | -$4.14B | +$2.08B | AMZN, META, V, BABA, ADSK | 13F-HR | 8/14/2020, 10:12 AM |
| Q1 2020 | 717 | $47.8B | +$3.56B | -$5.43B | -$1.87B | AMZN, BABA, V, META, ORCL | 13F-HR | 5/15/2020, 09:20 AM |
| Q4 2019 | 728 | $57.8B | +$3.98B | -$2.2B | +$1.78B | V, AMZN, BABA, META, ORCL | 13F-HR | 2/14/2020, 02:07 PM |
| Q3 2019 | 699 | $51B | +$1.91B | -$1.47B | +$439M | V, AMZN, META, BABA, ORCL | 13F-HR | 11/13/2019, 02:53 PM |
| Q2 2019 | 565 | $51.3B | +$1.52B | -$1.11B | +$408M | AMZN, V, META, BABA, ORCL | 13F-HR | 8/14/2019, 10:34 AM |
| Q1 2019 | 762 | $48.5B | +$2.25B | -$1.29B | +$963M | AMZN, V, BABA, META, ORCL | 13F-HR | 5/15/2019, 08:53 AM |
| Q4 2018 | 833 | $41.2B | +$1.94B | -$2.86B | -$920M | AMZN, V, BABA, META, ORCL | 13F-HR | 2/14/2019, 09:41 AM |
| Q3 2018 | 888 | $48.4B | +$1.16B | -$2.48B | -$1.32B | AMZN, V, META, BABA, ORCL | 13F-HR | 11/13/2018, 03:12 PM |
| Q2 2018 | 872 | $46.7B | +$3.16B | -$2.46B | +$700M | AMZN, META, BABA, V, ORCL | 13F-HR | 8/14/2018, 02:52 PM |
| Q1 2018 | 863 | $44.5B | +$1.71B | -$2.77B | -$1.06B | AMZN, BABA, META, V, ORCL | 13F-HR | 5/11/2018, 04:07 PM |
| Q4 2017 | 838 | $45.3B | +$1.84B | -$2.02B | -$176M | AMZN, META, BABA, V, ORCL | 13F-HR | 2/14/2018, 01:53 PM |
| Q3 2017 | 909 | $43B | +$1.82B | -$1.6B | +$218M | BABA, META, AMZN, V, CSCO | 13F-HR | 11/14/2017, 09:02 AM |
| Q2 2017 | 938 | $40.4B | +$2.14B | -$1.95B | +$191M | AMZN, META, BABA, ORCL, V | 13F-HR | 8/14/2017, 04:19 PM |
| Q1 2017 | 949 | $37.8B | +$1.36B | -$3.08B | -$1.72B | AMZN, META, CSCO, BABA, V | 13F-HR | 5/12/2017, 08:52 AM |
| Q4 2016 | 1,006 | $37.4B | +$3.53B | -$2.33B | +$1.21B | AMZN, INTC, META, CSCO, V | 13F-HR | 2/14/2017, 12:51 PM |
| Q3 2016 | 1,005 | $37.1B | +$2.99B | -$2.21B | +$780M | AMZN, META, INTC, BABA, CSCO | 13F-HR | 11/14/2016, 11:21 AM |
| Q2 2016 | 999 | $34.3B | +$2.59B | -$1.72B | +$870M | AMZN, META, INTC, CSCO, MNST | 13F-HR | 8/12/2016, 09:24 AM |
| Q1 2016 | 1,044 | $32.6B | +$2.63B | -$2.28B | +$343M | INTC, META, AMZN, CSCO, V | 13F-HR | 5/13/2016, 01:07 PM |
| Q4 2015 | 1,041 | $32.7B | +$3.51B | -$4.09B | -$584M | INTC, AMZN, META, BMY, V | 13F-HR | 2/12/2016, 12:16 PM |
| Q3 2015 | 1,013 | $31B | +$2.33B | -$1.91B | +$422M | INTC, AMZN, GLW, META, CSCO | 13F-HR | 11/13/2015, 11:12 AM |
| Q2 2015 | 907 | $32.9B | +$4.05B | -$2.65B | +$1.4B | INTC, GLW, AMZN, BMY, META | 13F-HR | 8/14/2015, 11:19 AM |
| Q1 2015 | 722 | $31.9B | +$2.48B | -$2.53B | -$56.5M | INTC, GLW, BMY, F, PPG | 13F-HR | 5/14/2015, 10:39 AM |
| Q4 2014 | 722 | $31.8B | +$3.08B | -$2.44B | +$641M | INTC, GLW, BMY, F, PPG | 13F-HR | 2/17/2015, 04:16 PM |
| Q3 2014 | 712 | $29.5B | +$1.95B | -$2.06B | -$117M | INTC, GLW, BMY, PPG, META | Restatement | 12/18/2014, 01:47 PM |
| Q2 2014 | 733 | $30B | +$2.28B | -$3.1B | -$823M | GLW, INTC, BMY, PPG, CSCO | 13F-HR | 8/14/2014, 02:49 PM |
| Q1 2014 | 729 | $30.2B | +$3.77B | -$2.02B | +$1.75B | GLW, INTC, BMY, GM, PPG | 13F-HR | 5/15/2014, 03:28 PM |
| Q4 2013 | 751 | $28.2B | $0 | $0 | GLW, INTC, BMY, GM, PPG | 13F-HR | 2/12/2014, 01:36 PM |